Cite
MLA Citation
C. Campani et al.. “The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib.” Digestive and liver disease, vol. 52, n.d., pp. e51–e52. http://access.bl.uk/ark:/81055/vdc_100101585211.0x000025